Founded in 2015, CRONET Sagl is a consulting and project management company for pharmaceutical R&D. Owing to collaboration with international trusted laboratories and with individual professionals with more than 30-year expertise in preclinical research, CRONET Sagl supports drug and medical device R&D addressing your projects through both operative and regulatory steps up to Phase I and beyond.
The scientific support covers project and study planning, audit and selection of Contract Research Organizations (CRO), monitoring the operational phases, documents review, support in authorization, including in-person meetings with regulatory authorities.
Continuous updating in innovative techniques and regulatory requests allows us to optimize the cost/benefit ratio through research and development. In addition to standard in vitro and in vivo studies required for international filing, our partners can offer top quality experimental models in innovative areas, such as imaging (US, MRI, Optical), toxicogenomics, structure-activity relationship (QSAR). These techniques allow a rapid candidate characterization, both during toxicological and pharmacodynamic screening, and during in-depth assessment of mechanism(s) of action (MoA).
A peer-review of data and reports is then worth to issue reliable study report for either regulatory purposes or scientific publications.